FIELD: medicine.
SUBSTANCE: method is divided into several stages like determining one or several markers level associated with state under diagnosis; determining one or several normalization markers usable instead of information describing morphological aspects of given sample; comparing and/or joining data describing marker levels as disease sign and normalization markers; and setting diagnosis of clinically relevant state.
EFFECT: high accuracy of diagnosis.
51 cl, 3 dwg, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR NEOPLASTIC DISEASE DETECTION ON THE BASIS OF SOLUBILISED PHYSIOLOGICAL SAMPLE | 2004 |
|
RU2405158C2 |
| METHOD FOR MULTI ANALYSES OF RARE CELLS EXTRACTED OR ISOLATED FROM BIOLOGICAL SAMPLES BY FILTERING | 2013 |
|
RU2641595C2 |
| METHODS FOR CLASSIFYING PATIENTS WITH SOLID CANCER | 2017 |
|
RU2745730C2 |
| METHOD FOR CONDUCTING MULTI-ASSAYS OF RARE CELLS EXTRACTED OR ISOLATED FROM BIOLOGICAL SAMPLES BY FILTRATION | 2013 |
|
RU2765808C2 |
| METHOD FOR CERVICAL CARCINOGENESIS DETECTION | 2015 |
|
RU2702334C2 |
| PEPTIDES OBTAINED FROM p16 FOR PREVENTION AND TREATMENT OF HPV-ASSOCIATED TUMOURS AND OTHER TUMOURS EXPRESSING p16 | 2012 |
|
RU2626542C2 |
| PHOSPHODIESTERASE 9A AS MARKER OF MALIGNANT TUMOR OF PROSTATE GLAND | 2010 |
|
RU2592668C2 |
| METHOD FOR EARLY AND PRECLINICAL DIAGNOSTICS OF CERVICAL CANCER | 2003 |
|
RU2251699C1 |
| METHOD FOR EARLIER DIAGNOSTICS OF CARCINOMAS | 1999 |
|
RU2217761C2 |
| REPRESENTATIVE DIAGNOSIS | 2016 |
|
RU2743169C2 |
